可孚医疗 （301087.SZ）
35.39 -0.18（-0.510%）
+ 收藏
今开：35.50 最高：35.95 成交量：1.01万手
昨收：35.57 最低：35.01 成交额：3594.46万
利润表（可孚医疗）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 2,248,651,846.83 | 1,558,610,242.89 | 807,154,893.30 | 2,853,694,939.62 | 2,123,962,814.37 | 1,519,115,209.72 | 855,367,818.78 |
| 营业收入(元) | 2,248,651,846.83 | 1,558,610,242.89 | 807,154,893.30 | 2,853,694,939.62 | 2,123,962,814.37 | 1,519,115,209.72 | 855,367,818.78 |
| 二、营业总成本(元) | 1,972,854,349.55 | 1,342,778,252.68 | 676,812,278.56 | 2,594,385,730.52 | 1,866,775,975.51 | 1,294,121,165.18 | 676,950,984.19 |
| 营业成本(元) | 1,093,280,391.26 | 768,786,622.09 | 404,949,938.30 | 1,618,660,760.96 | 1,160,503,818.10 | 819,475,746.23 | 417,709,510.86 |
| 研发费用(元) | 69,408,244.31 | 45,825,931.89 | 22,369,153.88 | 114,330,448.64 | 79,244,096.66 | 55,428,186.37 | 29,501,924.78 |
| 营业税金及附加(元) | 19,242,890.49 | 13,206,012.53 | 6,904,197.11 | 28,831,185.92 | 21,865,708.37 | 10,885,845.60 | 6,170,881.63 |
| 销售费用(元) | 711,660,470.44 | 466,692,929.36 | 218,526,875.35 | 740,704,222.71 | 525,231,626.62 | 353,587,339.01 | 195,901,260.69 |
| 管理费用(元) | 95,703,840.82 | 61,173,767.62 | 29,520,343.97 | 110,921,003.97 | 91,870,067.22 | 62,178,138.84 | 32,336,870.47 |
| 财务费用(元) | -16,441,487.77 | -12,907,010.81 | -5,458,230.05 | -19,061,891.68 | -11,939,341.46 | -7,434,090.87 | -4,669,464.24 |
| 其中：利息费用(元) | 13,117,673.97 | 8,506,755.38 | 2,722,588.16 | 13,502,605.05 | 6,881,627.06 | 8,638,715.46 | 2,640,846.37 |
| 其中：利息收入(元) | 32,183,399.30 | 22,071,412.44 | 9,533,132.21 | 34,305,257.97 | 23,683,270.61 | 16,937,668.56 | 8,963,963.29 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 2,489,572.92 | -2,554,432.17 | 7,537,888.73 | -1,562,660.43 | 33,363,522.57 | 21,981,035.40 | 10,088,049.52 |
| 加：投资收益(元) | 15,042,833.01 | 13,070,805.05 | -431,699.64 | 47,715,063.36 | 948,546.64 | -21,199.26 | -11,896.63 |
| 其中：对联营企业和合营企业的投资收益(元) | 462,018.88 | -101,772.68 | -431,699.64 | -130,244.39 | -88,163.97 | -64,186.25 | -11,896.63 |
| 资产处置收益(元) | -53,860.08 | 89,895.19 | 63,210.33 | 4,591,942.72 | 4,884,517.22 | 2,412,582.03 | 91,267.10 |
| 资产减值损失(元) | -31,678,905.69 | -26,467,986.43 | -21,442,996.61 | -52,179,582.10 | -50,683,392.16 | -40,108,496.52 | -33,659,171.45 |
| 信用减值损失(元) | -3,770,104.46 | -2,689,364.74 | -3,096,168.21 | -821,151.75 | 4,768,073.13 | 4,510,589.25 | -1,259,740.23 |
| 其他收益(元) | 36,926,459.14 | 17,320,266.65 | 6,305,399.39 | 37,675,469.03 | 30,470,381.47 | 21,132,866.92 | 3,897,926.57 |
| 四、营业利润(元) | 294,753,492.12 | 214,601,173.76 | 119,278,248.73 | 294,728,289.93 | 280,938,487.73 | 234,901,422.36 | 157,563,269.47 |
| 加：营业外收入(元) | 4,211,262.05 | 4,050,991.04 | 488,901.59 | 381,604.87 | 196,908.70 | 141,039.08 | 102,363.88 |
| 减：营业外支出(元) | 4,007,003.98 | 2,515,648.81 | 1,024,927.03 | 9,402,077.37 | 4,834,099.16 | 3,791,255.60 | 2,125,071.98 |
| 五、利润总额(元) | 294,957,750.19 | 216,136,515.99 | 118,742,223.29 | 285,707,817.43 | 276,301,297.27 | 231,251,205.84 | 155,540,561.37 |
| 减：所得税费用(元) | 43,019,932.60 | 31,433,077.06 | 17,703,210.12 | 32,837,212.62 | 33,924,360.25 | 31,518,916.19 | 22,167,077.42 |
| 六、净利润(元) | 251,937,817.59 | 184,703,438.93 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 | 133,373,483.95 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 251,937,817.59 | 184,703,438.93 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 | 133,373,483.95 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 251,916,521.29 | 184,976,831.58 | 101,221,564.63 | 254,279,785.84 | 241,956,330.46 | 198,910,330.69 | 134,514,033.42 |
| 少数股东损益(元) | 21,296.30 | -273,392.65 | -182,551.46 | -1,409,181.03 | 420,606.56 | 821,958.96 | -1,140,549.47 |
| 扣除非经常性损益后的净利润(元) | 218,789,240.55 | 166,046,179.50 | 91,784,209.64 | 201,151,337.34 | 194,328,053.83 | 170,758,699.53 | 124,957,593.86 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 1.24 | 0.91 | 0.50 | 1.24 | 1.16 | 0.95 | 0.65 |
| 二、稀释每股收益(元) | 1.23 | 0.90 | 0.49 | 1.24 | 1.16 | 0.95 | 0.65 |
| 九、综合收益总额(元) | 251,937,817.59 | 184,703,438.93 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 | 133,373,483.95 |
| 归属于母公司所有者的综合收益总额(元) | 251,916,521.29 | 184,976,831.58 | 101,221,564.63 | 254,279,785.84 | 241,956,330.46 | 198,910,330.69 | 134,514,033.42 |
| 归属于少数股东的综合收益总额(元) | 21,296.30 | -273,392.65 | -182,551.46 | -1,409,181.03 | 420,606.56 | 821,958.96 | -1,140,549.47 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-29 | 2024-04-29 | 2023-10-30 | 2023-08-30 | 2023-04-26 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 42 of 42 entries